We characterized CHIP and TI-CH in 421 patients with early-stage non–small-cell lung cancer (NSCLC) from the TRACERx study and in 49,351 patients from the MSK-IMPACT pan-cancer cohort.

Meanwhile, lung-on-chip interfaces remain top-of-mind in the Organ-on-a-chip market, particularly for conditions like chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis.

Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients.

/PRNewswire/ -- The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by 2033, growing at a ...

Advanced Applications: Oncology, Neurodegenerative Diseases, Lung Models, And Beyond Unfold Once confined to simpler liver or kidney constructs, organ-on-chip platforms now cater to an expanding ...

Organ-on-a-chip (OoC) technology refers to an in vitro ... The different types of organs involved in OoC models include the lung, brain, heart, liver, kidney, skin, and gut. The rising prevalence ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to aging, ...

Harvard no longer has a primate research center. But in 2009, Harvard’s Wyss Institute for Biologically Inspired Engineering ...

Much of the recent coverage of the latest Nvidia curbs frame it as more evidence that multi-billion-dollar dealmaking with Trump offers no guarantees of tariff reprieve. However, the reality is the ...

Already, this technology has been used to mimic various individual organs into a chip format, including the liver, lung, tumours, and muscles, among others. As the technology advances further ...